Martin Blankfard
About Martin Blankfard
Martin Blankfard serves as the Vice President of Operations Management at Epic Sciences, where he has worked since 2019. He has over 30 years of experience in product development and operations within the diagnostics industry, having held various leadership roles at companies such as Invivoscribe, QIAGEN, and ALPCO Diagnostics.
Current Role at Epic Sciences
Martin Blankfard serves as the Vice President of Operations Management at Epic Sciences since 2019. In this role, he is responsible for overseeing operations and ensuring efficient management of resources. His leadership contributes to the company's focus on advancing diagnostic technologies and improving patient outcomes. His tenure at Epic Sciences aligns with his extensive background in product development and operations management.
Previous Experience at Invivoscribe
Before joining Epic Sciences, Martin Blankfard worked at Invivoscribe as the Senior Director of Product Development from 2017 to 2019. His role involved leading product development initiatives, focusing on the creation and commercialization of diagnostic products. This position built on his previous experience in the diagnostics field and further developed his expertise in managing product life cycles.
Background in Assay Development at QIAGEN
In 2016, Martin Blankfard held the position of Director and Head of Assay Development at QIAGEN for a duration of 10 months. His responsibilities included overseeing the development of assays, which are critical components in diagnostic testing. This role contributed to his comprehensive understanding of diagnostic platforms and assay technologies.
Educational Qualifications
Martin Blankfard holds a Master of Science Degree in Physiology and a Bachelor of Science Degree in Food Science, both from the University of Maryland. His educational background provides a strong foundation in the scientific principles underlying his work in diagnostics and product development. He studied various disciplines including biochemistry, physiology, and toxicology during his academic career.
Extensive Experience in Diagnostics
Martin Blankfard possesses over 30 years of experience in platform development within veterinary and in vitro diagnostic (IVD) clinical diagnostics. His career includes roles in research and development, product management, and business development. He has led global product development teams and has a deep knowledge of various immunoassay diagnostic platforms, including ELISA, IHC, and flow cytometry.